Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492253 · ClinicalTrials.gov registry record · NA
First Complementary Foods and the Infant Gastrointestinal Microbiota
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05492253: Completed NA study, sponsored by University of Delaware.
NCT05492253 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05492253, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study evaluates the effect of different complementary foods on the gastrointestinal microbiota of exclusively human milk fed infants.
Primary Outcome
Composition of the gastrointestinal microbiota (family, genus, and species levels via shotgun metagenomic sequencing) before and after the introduction of solid food
Interventions
- OTHER Infant fruit
- OTHER Infant vegetable
- OTHER Infant meat
- OTHER Infant grain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2024-03-12 |
| Phase | NA |
What the finished NCT05492253 record still lists
NCT05492253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Infant fruit is the first listed.
NCT05492253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05492253 about?
NCT05492253 is a clinical study titled "First Complementary Foods and the Infant Gastrointestinal Microbiota". This study evaluates the effect of different complementary foods on the gastrointestinal microbiota of exclusively human milk fed infants.
What is the current status of trial NCT05492253?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-01-30. Estimated completion is 2024-03-12.
What interventions are being tested in trial NCT05492253?
The interventions under investigation include: Infant fruit (OTHER), Infant vegetable (OTHER), Infant meat (OTHER), Infant grain (OTHER).
Who is sponsoring clinical trial NCT05492253?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05492253's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI